Similarly, several groups confirmed the negative correlation of CD68+ TAMs in HL with patients’ survival and/or response to treatment [68,69,70,71,72,73,74,75], while the prognostic value of CD68+ macrophages was not reproduced by other groups [61,76,77,78,79]. This evidence concerns the gene CD68 and Hodgkins lymphoma.